319
Participants
Start Date
September 30, 2015
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
Reduced follow-up schedule
In the intervention group, the follow-up schedule will be limited to four follow-up visits at 3, 12, 24 and 36 months, under the specific condition that patients have easy and prompt access to care (specialised nurse of gynaecologist) if symptoms or questions occur. The content of the follow-up visits will be similar for both groups.
Jeroen Bosch, 's-Hertogenbosch
Noordwest ziekhuisgroep, Alkmaar
Meander Medisch Centrum, Amersfoort
Amstelland Ziekenuis, Amstelveen
AMC, Amsterdam
AVL, Amsterdam
OLVG, Amsterdam
Gelre Ziekenhuizen, Apeldoorn
Bravis, Bergen op Zoom
Tergooi, Blaricum
Amphia, Breda
Reinier de Graaf Hospital, Delft
Deventer Hospital, Deventer
Albert Schweitzer Ziekenhuis, Dordrecht
Catharina Hospital, Eindhoven
Medical Spectrum Twente, Enschede
Groene Hart, Gouda
Martini Hospital, Groningen
UMC Groningen, Groningen
Röpcke-Zweers Ziekenhuis, Hardenberg
Tjongerschans, Heerenveen
Zuyderland Hospital, Heerlerheide
Westfries Gasthuis, Hoorn
Medical Center Leeuwarden, Leeuwarden
Alrijne Ziekenhuis, Leiden
Leiden University Medical Center, Leiden
Maastricht University Medical Center, Maastricht
St. Antonius, Nieuwegein
Waterland Ziekenhuis, Purmerend
Bravis, Roosendaal
Franciscus Gasthuis, Rotterdam
Vlietland, Schiedam
Zuyderland, Sittard
Refaja, Stadskanaal
Haga hospital, The Hague
MC Haaglanden, The Hague
Elisabeth TweeSteden, TweeSteden, Tilburg
Elisabeth-TweeSteden, Tilburg
Bernhoven, Uden
Maxima Medisch Centrum, Veldhoven
VieCuri, Venlo
Streekziekenhuis Koningin Beatrix, Winterswijk
Zuwe Hofpoort, Woerden
Zaans Medisch Centrum, Zaandam
Langeland, Zoetermeer
Gelre Ziekenhuizen, Zutphen
Isala kliniek, Zwolle
Dutch Cancer Society
OTHER
Maastricht University Medical Center
OTHER
Leiden University Medical Center
OTHER
Comprehensive Cancer Centre The Netherlands
OTHER